City of Edinburgh, Scotland, United Kingdom In 2000 was created Scottish Widows Investment Partnership, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Edinburgh. The company was established in Europe in United Kingdom.
The overall number of key employees were 13.
The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Health Diagnostics, Therapeutics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight 7TM Pharma, ARYx Therapeutics, Radius Health. For fund there is no match between the location of its establishment and the land of its numerous investments - United States.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Scottish Widows Investment Partnership, startups are often financed by MPM Capital, Wellcome Trust, HealthCare Ventures. The meaningful sponsors for the fund in investment in the same round are MPM Capital, Wellcome Trust, HealthCare Ventures. In the next rounds fund is usually obtained by MPM Capital, BB Biotech Ventures, Wellcome Trust.
The important activity for fund was in 2007. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2014. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this Scottish Widows Investment Partnership works on 9 percentage points more the average amount of lead investments.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 51.com | China, Shanghai |
| Essilor | Charenton-le-pont, France, Ile-de-France |
| Liande Venture Capital | China, Hangzhou, Zhejiang |
| Nuohan Hudong Keji | Beibei, China, Chongqing |
| OncoMethylome | Belgium, Liège, Liege |
| Pera Global | Beijing, Beijing, China |
| Startupbootcamp FinTech Mumbai | India, Maharashtra, Mumbai |
| The Business Angel | - |
| Willendorff Technologies | Bavaria, Germany, Munich |
| Yongfeng Xinyouhui | - |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Radius Health | $66M | 26 Jul 2011 | Cambridge, Massachusetts, United States | ||
Radius Health | $15M | 20 Nov 2008 | Cambridge, Massachusetts, United States | ||
Radius Health | $57M | 02 Apr 2007 | Cambridge, Massachusetts, United States | ||
Cara Therapeutics | $24M | 28 Nov 2006 | Connecticut, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Radius Health | $66M | 26 Jul 2011 | Cambridge, Massachusetts, United States | ||
Radius Health | $15M | 20 Nov 2008 | Cambridge, Massachusetts, United States | ||
Radius Health | $57M | 02 Apr 2007 | Cambridge, Massachusetts, United States | ||
Cara Therapeutics | $24M | 28 Nov 2006 | Connecticut, United States |
